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ABSTRACT - Purpose: Delineate the selected pharmacodynamics of a naturally occurring stilbene 3’Hydroxypterostilbene. Objective: Characterize for the first time the pharmacodynamics bioactivity in several
in-vitro assays with relevant roles in heart disease, inflammation, cancer, and diabetes etiology and
pathophysiology. Methods: 3’-Hydroxypterostilbene was studied in in-vitro assays to identify possible
bioactivity. Results: 3’-Hydroxypterostilbene demonstrated anti-oxidant, anti-inflammatory, cytotoxic, antiadipogenic, histone deacetylase, and sirtuin-1 inhibitory activity. Conclusions: The importance of
understanding individual stilbene pharmacologic activities were delineated. Small changes in chemical structure
of stilbene compounds result in significant pharmacodynamic differences.
This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For
Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.
__________________________________________________________________________________________
Sphaerophysa salsula, which is used in Chinese
folk medicine to treat hypertention (1). 3’Hydroxypterostilbene was evaluated for its effects
in-vitro and in-vivo against human cancer cell lines
(COLO 205, HCT-116, and HT-29) and in nude
mice (2). Researchers of this study found that 3’Hydroxypterostilbene induced apoptosis and
autophagy to inhibit cell growth. Specifically,
down-regulation of phosphatidylinositol 3-kinase
and mitogen-activated protein kinase was observed.
In the in-vivo model of the same study, researchers
found that 3’-Hydroxypterostilbene was able to
reduce tumor burden in nude mice bearing COLO
205 tumor xenografts. Specifically, downregulation
of
cyclooxygenase-2,
matrix
metallopeptidase-9, vascular endothelial growth
factor, and cyclin D1, and apoptosis was observed.
Tolomeo et.al. evaluated 3’-Hydroxypterostilbene
for its effects in sensitive and resistant leukemia
cells (3). 3’-Hydroxypterostilbene was determined
to be effective at inducing apoptosis in HL60 and
_________________________________________

INTRODUCTION
Studies on natural products continue to be evaluated
for
their
therapeutic
potential.
3’hydroypterostilbene, C16H16O4, MW 272.29 g/mol,
is stilbene derived through the phenylpropanoid
pathway that is an analogue of resveratrol, a
compound very widely studied and available as a
nutraceutical (Figure 1).

Figure 1. Chemical Structure of 3'-Hydroxypterostilbene

3’-Hydroxypterostilbene is structurally related to
resveratrol, which is a well-studied natural product
with associated health benefits. Reportedly, 3’hydropyterostilbene has been isolated from
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were purchased from Central Stores (Washington
State University, Pullman, WA, USA) or VWR
International (West Chester, PA, USA). Assay
measurements using a microplate reader used a
BioTek Synergy HT Multi-Mode Microplate
Reader (Winooski, VT, USA) with Gen 5 software,
unless otherwise indicated.
3T3-L1 fibroblasts (murine fibroblasts), HCT116 (human colorectal carcinoma), Hep-G2 (human
hepatocellular
carcinoma),
HT-29
(human
colorectal adenocarcinoma), MDA-MB-231 (human
estrogen receptor negative breast adenocarcinoma),
and PC-3 (human prostate adenocarcinoma) were
purchased from American Type Culture collection
(ATCC, Manassa, VA, USA).
The Adipogenesis (Catalog No. 10006908),
Antioxidant (Catalog No. 709001), Cyclooxygenase
Inhibitor Screening (Catalog No. 560131), Histone
Deacetylase (HDAC) Activity (Catalog No.
10011563), and SIRT1 Direct Fluorescent
Screening (Catalog No. 10010401) Assay Kits were
purchased from Cayman Chemical Company (Ann
Arbor, MI, USA). Prostaglandin E2 Biotrak™
Direct Assay Kit (RPN222) was purchased from
GE Healthcare Biosciences (Pittsburgh, PA, USA).

HUT78 cells. Additionally, apoptosis was induced
by 3’-Hydroxypterostilbene, in HUT78B1 and
HUT78B3, Fas-ligand resistant lymphoma cell lines,
and in HL60-R and K562-ADR, multi drugresistant leukemia cell lines. In this study it appears
that 3’-Hydroxypterostilbene induces apoptosis
through an intrinsic apoptotic pathway with no
cytotoxic effects in normal hemopoietic stem cells.
Biomedical literature appears to have only two
published studies evaluating the pharmacodynamics
of 3’-Hydroxypterostilbene. Both studies evaluated
the anti-cancer effects in colon cancer or leukemia
cells. The objective of the study was to characterize
the effects of 3’-Hydroxypterostilbene in vitro. We
wanted to replicate the anti-cancer effects
previously
reported,
and
evaluate
3’hydroypterostilbene for its potential as a therapeutic
for metabolic disorders. With the growing number
of metabolic disorders and use of natural products,
new and effective therapies are of interest. Since the
underlying causes of metabolic disorders are only in
part delineated, with origins in inflammation and
gene dysregulation, we take a multifaceted
approach to assessing the therapeutic potential of
3’-Hydroxypterostilbene. To our knowledge, this
will be first study assessing the effects of 3’Hydroxypterostilbene in cancer cell lines of the
liver and prostate, anti-oxidation, anti-adipogenesis,
anti-inflammation, histone deacetylase HDAC), and
sirtuin 1 (SIRT1) inhibitory activities.

XlogP Determinations
The
partition
coefficient
(XLogP)
was
experimentally investigated using the shake flask
method at ambient temperature (23 ± 2°C) with
spectrophotometric analysis (4-5) and by a HPLC
analytical assay (6).
For the shake flask method HPLC grade water
and octanol were combined in a 2 L Erlenmeyer
flask to saturate for 24 hours on a plate stirrer and
allowed to separate for 24 hours. 3’Hydroxypterostilbene
was
evaluated
at
concentrations (5, 10, and 50 mg/33 mL) with
varying volumes of the saturated water and octanol
in proportions of 1:1, 2:1, and 1:2 (v/v). Mixtures
were rotated 100 times to facilitate sufficient
mixing. Samples were allowed to separate into
octanol and water entities and isolated from each
other. Standard curves (0-100 μg/mL) were
prepared both in HPLC grade water and octanol. A
reference sample of pterostilbene with a reported
partition coefficient value of 3.8 (7) was also
subjected to the same treatment as 3’Hydroxypterostilbene for comparison. All samples
were assessed by spectroscopy in replicate (n = 3)
and assayed in replicate (n = 4), with a peak
absorbance at 325 nm.

METHODS
Chemicals and Reagents
3’-Hydroxypterostilbene and pterostilbene were
generously provided by the Sabinsa Corporation®
(Piscataway, NJ, USA). Dimethyl sulfoxide
(DMSO), trypsin-ethylenediamenetetraacetic acid
(Trypsin-EDTA, Catalogue No. T4174), trypan blue,
sodium bicarbonate, phosphate-buffered saline
magnesium and calcium free (PBS), cell culture
tested sodium carbonate, 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES), sodium
pyruvate, Dulbecco’s Modified Eagle Medium
(DMEM), McCoy’s 5A Medium, Minimum
Essential Medium, RPMI 1640 medium (RPMI),
and penicillin-streptomycin were purchased from
Sigma-Aldrich® (St Louis, Missouri, USA). Alamar
Blue® was purchased from Trek (Cleveland, OH,
USA). Heat-inactivated fetal bovine serum (FBS)
was purchased from Equitech-Bio Inc. (Kerrville,
TX, USA). TPP, Sartdet, and BD Biosciences T25
(5 mL), T75 (15 mL), and T125 (25 mL) flasks
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room temperature. This fluorescing product was
quantified using a microplate reader with excitation
set at 530 nm and emission set at 590 nm
(Cytofluor® 4000 fluorescence multi-well plate
reader, Applied Biosystems, USA). Modeling and
analysis of data was carried out using WinNonlin®
Version 5.2 and Microsoft® Excel. This assay is
based on the ability of the live cells to reduce
resazurin to resorufin thus producing a pink
fluorescing product.

When applying the analytical assay, samples
were dried to completion using a SpeedVac®
(Savant SC110 A SpeedVac® Plus Concentrator
with Universal Vacuum System (UVS400), Savant
Instruments, Inc, Holbrook, NY, USA). Internal
standard (4-methylumbelliferone, 0.10 mL) was
added to the dried samples and dried to completion.
Samples were resuspended in mobile phase (0.40
mL), injected (0.05 mL) into the system, and the
developed analytical method applied (6). The peak
area ratios were determined for the octanol and
aqueous phase taking into consideration the total
volume of solvents for all standards and samples
(8); concentrations of unknown samples were
determined using linear regression from the
standard curve and the XLogP was calculated. The
retention time of 3’-Hydroxypterostilbene was
notated and unweighted least squares linear
regression applied to determine the XLogP for the
unknown (8-11).

Anti-oxidant Determination
All reagents were prepared according to the
manuscript provided with the Antioxidant Assay
Kit (13). A 6-hydroxy,2,5,7,8-tetramethylchroman2-carboxylic acid (Trolox) standard was prepared at
concentrations specified as this compound is a
readily used marker of anti-oxidant activity. The
assay as carried out to manufacturer specifications
with 3’-Hydroxypterostilbene treatments at final
concentrations of 1-250 µg/mL in DMSO evaluated
for antioxidant capacity. The reaction was initiated
with addition of hydrogen peroxide, incubated on
an orbital shaker for 5 minutes at room temperature
and read using a plate reader at 750 nm. Average
values were calculated and graphed to the standard
as absorbance versus Trolox concentration.
Unknown sample anti-oxidant capacities were
calculated using unweighted least squares linear
regression.

Cytotoxic Activity
Cell Culture
All cell line culture conditions included temperature
at 37°C, 5% CO2 atmosphere. All media used to
maintain cell lines were prepared using suggested
specification from the manufacturer, degassed, and
filtered under aseptic conditions under a laminar
flow hood. HCT-116 and HT-29 were maintained
in McCoy’s 5A Medium modified with 10% FBS,
penicillin-streptomycin solution (10 mL/L), and
HEPES (6.0 g/L). Hep-G2 was maintained in MEM
with 10% FBS and penicillin-streptomycin solution
(10 mL/L). MDA-MB-231 was maintained in
DMEM with 10% FBS, penicillin-streptomycin
solution (10 mL/L), HEPES (2.4 g/L), and sodium
pyruvate (110.4 mg/L). PC-3 was maintained in
RPMI modified with 10% FBS and penicillinstreptomycin solution (10 mL/L).
Cells were seeded after counting using a trypan
blue assay to predetermined optimum cell density in
a 96 well plate as to avoid over confluence on day
one and returned to the incubator. On day two, cells
were treated with fresh media with 3’Hydroxypterostilbene yielding final concentrations
1-250 µg/mL dissolved in DMSO and returned to
the incubator.

Anti-adipogenic Determination
Cell Culture
3T3-L1 fibroblasts were cultured in DMEM
modified with 10% at 37°C, 5% CO2 atmosphere.
Cells were seeded on day one in a 96 well plate at
30,000 cells/well and grown to 75% confluence. All
reagents were prepared according to manufacture
recommendations (14). 3T3-L1s were chemically
differentiated from fibroblast type cells into preadipose cells to mature adipose cells after
stimulation with isobutylmethylxanthine (IBMX),
insulin,
and
dexamethasone
(15-16).
Dexamethasone is the primary adipogenic agent
used in combination with IBMX and insulin have
synergistic roles in adipogenesis (15, 17). These
cells replicate even if not able to differentiate, thus
there is a distinct difference in morphology between
those cells experiencing cytotoxic effects versus
those cells that are unable to differentiate due to
polyphenol treatment. On day three, growth
medium was changed to induction medium [DMEM
modified with 10% FBS, IBMX, insulin,

Alamar Blue Assay
On day five, cells underwent an Alamar Blue Assay
(12). Briefly, treatment media was removed and
replaced with 10% Alamar Blue in fresh media.
Plates were returned to the incubator and brought to
715
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(19). Preliminary detection of PGE2 was assessed at
630 nm and at 450 nm within 10 minutes with a
plate reader. Optical density for each standard and
samples was calculated and the percent bound
(%B/B0) was determined. A %B/B0 versus
logarithmic PGE2 concentration from the standards
linear regression curve fit was used to determine the
amount of PGs in each sample.

dexamethasone, and 3’-Hydroxypterostilbene]. On
day six, induction medium was changed to insulin
medium [DMEM modified with 10% FBS with 3’Hydroxypterostilbene]. Media was refreshed on day
eight. Treatment with 3’-Hydroxypterostilbene was
carried out at concentrations of 1-250 µg/mL. On
day ten, quantification of lipid droplet was assessed
using Oil Red O. Reagents were prepared following
manufacturer instructions. After extraction of Oil
Red O from lipid droplets, quantification of lipid
accumulation was accomplished by using a
microplate at 520 nm based on the premise that a
proportional increase in lipid accumulation and
absorbance exists.

Histone Deacetylase (HDAC) Activity
All reagents were prepared according to the
manufacturer instructions provided with the HDAC
Activity Assay Kit (20). An acetylated substrate
was incubated with 3’-hydroxypterostilbene alone
or 3’-Hydroxypterostilbene with Trichostatin A
(known HDAC inhibitor readily used as a
reference) at specified concentrations (1-100
µg/mL). If the compound of interest is a HDAC
inhibitor, the sensitized substrate decreases in
fluorescence when treated with the HDAC
developer. This assay was read at an excitation
wavelength of 360 nm and an emission wavelength
of 460 nm to quantify HDAC activity. A linear
association was established by fluorescence versus
deacetylated standard from for each sample. HDAC
activity was determined accounting for dilution, as
one unit is defined as the amount of enzyme leading
to the formation of 1.0 nmol of deacetylated
compound per minute at 37°C.

Anti-inflammatory Determination
Cyclooxygenase Inhibition
The three day COX Inhibitor Screening Assay Kit
is used to identify COX-1 and/or COX-2 inhibitors
(18). All reagents were prepared to manufacturer
specifications and carried out accordingly. 3’Hydroxypterostilbene was prepared over the
concentration range of 1-250 µg/mL in DMSO.
Ibuprofen and etodolac or deracoxib, NSAID and
COX-2 specific inhibitors, respectively, were used
as controls. The assay was assessed with a plate
reader at 420 nm within 10 minutes using the plate
reader. Optical density for standards and samples
were calculated with the percent bound (%B/B0).
A %B/B0 versus log concentration 4-parameter
logistic curve fit was used to determine the amount
of PGs in each sample.

Sirtuin 1 inhibitory Activity
All reagents were prepared according to the
manuscript provided with the SIRT1 Direct
Florescent Screening Assay Kit (21). In this assay
the p53 sequence was incubated with SIRT1
(enzyme),
cosubstrate
(NAD+),
and
3’Hydroxypterostilbene
(1-250
µg/mL).
The
inhibitory activity was monitored using a
fluorescence-based assay to screen for inhibitors or
activators by quantification of the sensitized
deacetylated substrate. The amount of deaceylation
is proportional to the amount of fluorescence, which
was able to determine if the compound is an
inhibitor or an activator. The activity of the selected
compounds can be compared to sirtinol, a known
inhibitor (21) or to resveratrol, a known activator
(22). Plates were read with excitation (350 nm) and
emission (460 nm) for this fluorescence-based assay.
The average fluorescence for each sample was
determined and the percent ratio of inhibition to
activation was calculated; thus a negative number
indicated activation of SIRT1.

In-Vitro Inflammatory Bowel Disease
HT-29 cells were cultured and seeded in 96 well
plates at a cell density of 10,000 cells per well and
grown to ~80% confluence at 37°C, 5% CO2
atmosphere. At confluence, cells were serum
starved. After 24 hours, treatment groups with 3’Hydroxypterostilbene (1-250 µg/mL in DMSO)
either with TNF-α (20 ng/mL) or without TNF-α
was dissolved in media with serum (treatment
media). Treatment was carried out at 37°C with 5%
CO2 atmosphere for 24 hours. Medium was
collected the following day and stored at -80°C
until further analysis using a commercially
available ELISA kit. Prostaglandin E2 Biotrak™
Direct Assay Kit was utilized to indirectly quantify
PGE2 synthesis. The assay is based on the
competition between PGE2 and PGE2–peroxidase to
the limited amount of binding sites on the plate. All
reagents were prepared and carried out according to
the manufacturer instructions provided with the kit
716
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linear and quadratic models were lower for the
quadratic models. For the pterostilbene the average
quadratic function for the standard curve for
pterostilbene in octanol can be described as y =
7.45x2 + 28.43x – 14.65 and in water can be
described as y = -2.58x2 + 58.63x – 18.92;
respectively the average correlation coefficients are
0.99 and 0.99. The average quadratic function for
the standard curve for 3’-Hydroxypterostilbene in
octanol can be described as y = -4.10x2 + 66.10x –
24.05 and in water can be described as y = -21.93x2
+ 84.61x – 24.55; respectively the average
correlation coefficients are 0.99 and 0.99. The
experimental XLogP was determined to be 3.18.
Using linear regression the LogD was determined to
be 2.78. Experimentally, pterostilbene has a
partition coefficient of 3.57.
Through this study the developed analytical
method was successful. Differences in retention
times
were
observed
between
4methylumbelliferone
(6
minutes),
3’Hydroxypterostilbene
(15
minutes)
and
pterostilbene (26 minutes). The partition coefficient for 4-methylumbelliferone is reported as
1.9 (25). A relationship between retention time and
LogD (R2 = 0.98) was established which can be
described as retention time = 10.44 (LogD) - 13.248.

STATISTICAL ANALYSIS
Data were compiled and presented as mean ±
standard deviation (SD) or mean ± standard error of
the mean (S.E.M.) where appropriate. Where
possible, WinNonlin 5.2 modeling software was
used to determine statistical significance and
inhibitory concentration values. A two tailed,
unpaired t-test was used to compare controls to
treatments. Significance was noted p-values <0.05.
Generally, significance from negative controls are
indicated as * p<0.05, ** p<0.01, and *** p<0.005.
Significance from positive controls are indicated as
# p<0.05, ## p<0.01, and ### p<0.001.
RESULTS
XlogP Determinations
Experimental values were compared to a computer
generated CLogP value using New ClogP
Calculator, (University of Massachusetts at Boston
General
Biology
Website,
http://intro.bio.umb.edu/111112/OLLM/111F98/newclogp.html, Boston, MA,
USA).
The reference sample, pterostilbene, has a
reported partition coefficient of 3.8 and 4.1 (7, 23).
The CLogP for pterostilbene that was generated has
a value of 3.69. The ADMET Predictor™
Moriguchi model of predicted partition coefficient
was 2.91 for pterostilbene. According to Sabinsa®
from whom we have obtained 3’Hydroxypterostilbene, a LogD value of 3.36 is
reported. The CLogP generated from the computer
program determined that 3’-Hydroxypterostilbene
has a CLogP of 3.39 (
Figure 2). The ADMET Predictor™ Moriguchi
model of predicted partition coefficient generated a
value of 2.88 for 3’-Hydroxypterostilbene.
A three-parameter polynomial model was used
to describe standard curves and unknown
concentrations were calculated for each sample.
This model was statistically a significantly better fit
as determined from an F-test. The partition
coefficient was determined from the logarithmic
ratio of the concentration of octanol to water,
adjusting for dilution and volume. The octanol and
methanol p-values are 1.044E-20 and 0.047,
respectively. Another objective assessment to grade
the models to determine which model fits the
experimental data best is Akaike Information
Criterion (AIC) (24). In this assessment the lower
the AIC value the better. The AIC values for the

Cytotoxicity – alamar blue assay
Cell viability assays often evaluate the percentage
of cell survival. No significant differences were
detected from untreated human controls over the
screening concentration range; therefore, anticancer
activities are evaluated. 3T3-L1 was included for
the lipogenesis study. No significant differences
were observed. 3’-Hydroxypterostilbene had an
established concentration-dependent cytotoxic
effect on the cell lines evaluated (

Figure 3). The IC50 values for HCT 116, MDA-MB-

231, PC-3, and HEPG2 are 7.62 ± 0.19 µg/mL,
18.06 ± 6.8 µg/mL, 23.29 ± 8.48 µg/mL, and 8.38 ±
0.00 µg/mL, respectively.
Antioxidant Activity
Assays that can be used to measure anti-oxidant
activity
include
chemiluminescence,
cell
morphology, and carbon monoxide production (2627). The Folin-Ciocalteu assay measures total
phenolics in a sample and after, has a strong
717

J Pharm Pharm Sci (www.cspsCanada.org) 18(5) xxx - xxx, 2015

of myoglobin) and hydrogen peroxide, which
converts the phenothiazine compound ABTS to
produce a radical cation (26, 29). In the presence of
anti-oxidants in the sample, oxidation of ABTS to
ABTS•+ by metmyoglobin is inhibited. The resulting
chromogen has a peak absorption of 645-815 nm.

correlation with DPPH radical scavenging activity
(28). Alternatively, in this study antioxidant
capacity of 3’-Hydroxypterostilbene was measured
by the Trolox equivalent anti-oxidant capacity assay
(27). The principle behind this method is the
formation of the ferryl myoglobin (oxygen carrying
protein) radical from metmyoglobin (oxidized form
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Figure 2. CLogP Values. The calculated partition coefficient of (A) 3’-Hydroxypterostilbene and reference sample (B)
pterostilbene using the NewClogP Calculator. (ADD SHORT DESCRIPTION OF THIS DIAGRAM)

Figure 3. Cytotoxicity of 3'-Hydroxypterostilbene. HCT 116: human colorectal carcinoma; MDA-MB-231: human
breast adenocarcinoma, PC-3: human prostate adenocarcinoma, HEPG2: human hepatocellular carcinoma, 3T3L1:
(normal murine fibroblasts). Data is expressed as mean ± SEM, n = 4.
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Figure 4. Anti-oxidant Activity of 3'-Hydroxypterostilbene in Trolox Equivalents (µg/mL). Data are presented as mean ±
SD, n=2-3. Significance from negative controls are noted as ** p<0.01 and *** p<0.005.

Hydroxypterostilbene did not appear to have a wellestablished concentration-effect relationship over
the concentration range assessed (

Vehicle (DMSO) only samples had a low antioxidant capacity (0.14 mM ± 0.006). 3’Hydroxypterostilbene
has
a
concentrationdependent anti-oxidant
activity
over
the
concentration range. Significant differences were
observed at 50 and 100 µg/mL from controls.
Treatment at 250 µg/mL approached significance
(p=0.058). At 10 µg/mL or 54.16 µg/mL (0.22
mM)
Trolox
equivalents
of
3’Hydroxypterostilbene indicates a 5-fold greater
anti-oxidant capacity than the gold standard Trolox
(Figure 4). However, at higher concentrations (100
and 250 µg/mL) 3’-Hydroxypterostilbene is equal
to or less than comparable levels of Trolox (100.2
and 129.88 µg/mL, respectively).

Figure 5), although there appears to be a reduction
of induced adipogenesis over all concentrations
assessed. The 50 and 100 μg/mL concentrations
were able to significantly reduce adipogenesis
compared to negative control. There were no
significant differences between genestein and 3’Hydroxypterostilbene at comparable concentrations.
Treatment at 250 µg/mL approached significance
(p=0.052).

Anti-adipogenic Activity
Cytotoxicity of 3-Hydroxypterostilbene was
evaluated with no significant differences detected.
In this assay, the negative control (Ctl) consisted of
cells chemically differentiated and maintained, and
modified with the vehicle (DMSO), which was
considered to represent 100% differentiation and
lipid accumulation. Genistein, the positive control,
is an isoflavonoid known to have anti-adipogenic
properties. Genistein was able to reduce
adipogenesis at all concentrations evaluated. 3’-

Anti-inflammatory Activity
Inflammation is the direct reaction to stimuli, in
which immunomodulators such as cyclooxygenases,
prostaglandins (PG), prostacyclins, thromboxanes,
leukotrienes, and lipoxygenases mediate the body’s
response. Immunomodulator synthesis are inhibited
by non-steroidal anti-inflammatory drugs (NSAIDs),
steroids,
receptor
level
antagonists,
and
lipoxygenase inhibitors (33).

720
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Figure 5. Anti-Adipogenic Activity of 3'-Hydroxypterostilbene. Data is expressed as mean ± S.E.M., n=4. Significance
from negative controls are noted as * p<0.05 and ** p<0.01.

3’-Hydroxypterostilbene did not appear to have a
concentration-effect relationship after induction of
inflammation as quantified by the synthesis of
PGE2 (

Cyclooxygenase 1 and Cyclooxygenase 2
Inhibition
Cyclooxygenases are enzymes that are involved
with the synthesis of prostaglandins, thromboxanes,
and
prostacyclins.
3’-Hydroxypterostilbene
demonstrates both COX-1 and -2 inhibitory
activities in a dose independent manner (Figure 6).
For COX-1 activity, 3’-Hydroxypterostilbene (1, 10,
and 250 μg/mL) had p-values that approached
significance (p=0.08). Ibuprofen demonstrated a
concentration dependent inhibition. Statistically
significant differences were observed only in COX1 inhibition at concentration of 10 μg/mL compared
to ibuprofen at 250 μg/mL. Compared to ibuprofen,
3’-Hydroxypterostilbene appeared to have better
COX-1 inhibition. COX-2 inhibition after treatment
with
3’-Hydroxypterostilbene
approached
significance at 10 and 250 μg/mL, p=0.051 and
0.054, respectively. However, 1 μg/mL treatment of
3’-hydroxtyperostilbene was significantly different
from controls (p=0.037). The only significant
difference between the positive control (deracoxib)
and 3’-hydroxtyperostilbene was at 1 μg/mL
(p<0.001).

Figure 7). 3’-Hydroxypterostilbene did not induce
inflammation nor disrupt basal levels of PGE2
synthesis to a statistically significant extent from
controls. The inhibitory effects of 3’Hydroxypterostilbene was most apparent at 1
µg/mL but was reduced at all concentrations;
although not significantly different from
dexamethasone. A dose dependent effect was
observed after treatments of 10 µg/mL.
Dexamethasone did have an effect in reducing
inflammation but did not appear to be in a dose
dependent manner.

Histone Deacetylase Activity
A value below the control, Trichostatin A, a known
HDAC inhibitor, indicates a reduction in HDAC
activity indicating HDAC inhibition. Values above
this control indicate activation of HDAC activity, as
an increase in HDAC activity. 3’-

In-Vitro Inflammatory Bowel Disease
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Hydroxypterostilbene inhibited the activity of
HDAC and reduces HDAC activity compared to
control; as such a HDAC inhibitor (

120

Figure 8). There was a significant different between

control (DMSO) and 50 µg/mL.
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100
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Figure 6. Cyclooxygenase Inhibition by 3'-Hydroxypterostilbene. (A) COX-1 and (B) COX-2 inhibitory activity of 3’Hydroxypterostilbene. Data are presented as a mean ± S.E.M., n = 4. Significance from negative control is noted as *
p<0.05. Significance from positive control is noted as ### p<0.001.
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Figure 7. PGE2 Synthesis. Amount of PGE2 synthesized after no induction and induction with TNF-α and treatment with
and without 3’-Hydroxypterostilbene compared to dexamethasone. Data are presented as a mean ± S.E.M., n = 4.
Significance from negative controls are expressed as * p<0.05 and ** p<0.01. Significance from positive controls are
expressed as # p<0.05.

Figure 8. HDAC Activity. Data are presented as mean ± S.E.M., n=3. Significance from negative control is indicated as *
p<0.05.

Figure 9. SIRT1 Inhibition. Data are presented as a mean ± S.E.M., n = 3.
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A single 3’-hydroxyl group on the B-ring and a
saturated heterocyclic C-ring has been suggested as
being causes of reduced anti-oxidant capacity (27).
3’-Hydroxypterostilbene appeared to have
concentration-dependent
anti-oxidant
activity
greater than that of Trolox. Anti-oxidant capacity of
3’-Hydroxypterostilbene, reported here for the first
time. At lower concentrations (1, 10, and 50
µg/mL),
3’-Hydroxypterostilbene
prevents
oxidation at better levels than Trolox does but is
reduced with an increase in concentration. Through
this investigation it is evident that the selected
polyphenols maintain their anti-oxidant activity like
several other related stilbenes, in spite of small
structural modifications. It is speculated that an
increase in hydroxyl groups can increase the antioxidant capacity. As a variety of diseases are
associated with an imbalance of oxidants/antioxidants, 3’-Hydroxypterostilbene may aid in
restoration of a balance.
Concentrations of 3’-Hydroxypterostilbene
were comparable to genistein in reducing
adipogenesis. At the two highest concentrations it is
possible that solubility may have been an issue as
there was a decrease in anti-adipogenic activity by
3’-Hydroxypterostilbene. The lipophilicity may
have played a role in the uptake of 3’Hydroxypterostilbene by cells for anti-adipogenic
activity. It appears that 3’-Hydroxypterostilbene
was most effective at inhibiting adipogenesis at 50
µg/mL. Future studies warrant a closer look at 3’Hydoxypterostilbene
along
with
selected
polyphenols and its effect on reducing obesity.
The expression of COX varies from tissue to
tissue. COX-1 is involved in normal cell
functioning typically involving mucosal integrity,
while COX-2 is expressed after being induced by
mitogenic
stimuli
(phorbol
esters,
lipopolysaccharides, and cytokines), suggesting
involvement with neoplastic and inflammatory
conditions (34). Due to COX-2’s role in the
biosynthesis of PGs under acute inflammatory
conditions, COX-2 is the target of NSAIDs and
COX-2
inhibitors.
Because
of
various
complications with current treatments, an
alternative agent for COX mediated inflammation is
necessary, making phytotherapeutic agents like
polyphenols potentially attractive alternatives. A
reduction in inflammation can be helpful in
reducing certain cancers and cardiopulmonary
diseases and other chronic conditions (35). In
particular, it appears that 3’-Hydoxypterostilbene

Sirtuin 1 Inhibitory Activity.
3’-Hydroxypterostilbene acted as both an activator
at mid-concentrations (10 and 50 µg/mL) evaluated
and also an inhibitor at the lower (1 µg/mL) and
upper (100 µg/mL) concentrations evaluated
(Figure 9). The change of resveratrol from an
activator to an inhibitor at higher concentrations
(100 and 250 µg/mL) may be due to inherent
properties of resveratrol as an unstable molecule
and/or problems with solubility or a complex
concentration-effect relationship.
DISCUSSION
It is likely that some of the pharmacodynamic
responses are directly related to the structure of 3’Hydroxypterostilbene. The New ClogP program
uses an algorithm including the chemical moieties
of the compound to determine the CLogP. Using
the ADMET Predictor™ Version 5.0 the Moriguchi
model of predicted partition coefficient was also
employed. A disadvantage to this method is that it
is an endpoint measurement not a thermodynamic
measurement. The XLogP was assessed through
the use of three different methods and determined to
be relatively comparable with the values utilizing
predictive programs and from cited sources. The
partition coefficient of the reference pterostilbene
was 2.91-3.69 and 3’-Hydroxypterostilbene ranged
from 2.88-3.39. In particular, from the experimental
data a true thermodynamic octanol-water partition
coefficient is determined which is a major
advantage to the HPLC assay. As an alternative, a
library of samples with known partition coefficients
can be assayed using the developed method for 3’Hydroxypterostilbene. A LogP-retention time plot
can be generated to form a linear relationship. A
pattern emerged indicating a decreased lipophilicity
of 3’-Hydroxypterostilbene compared to the
reference, which was supported by the application
of the developed analytical method with an earlier
retention time. Having lipophilic properties may
have played a role in activities with regards to
solubility and permeability.
In our cytotoxic studies we were able to
reproduce similar results as other researchers (3).
3’-Hydroxypterostilbene appeared to have the
greatest effects in prostate cancer cell line, PC-3.
Structural features of polyphenols that have been
associated with enhancing anti-oxidant capacity
include the presence of a 3-hydroxyl group on the
-ring and/or a hydroxyl group on the C3 position.
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use of NAD as a cofactor (22, 42). Sirtuin 1
(SIRT1) activity is of particular interest as there is
abundant information on the roles in regulation
and/or
control
of
metabolic
activity,
neurodegenerative diseases, and cell proliferation
(22, 43-45). In an in-vitro model, SIRT1 regulated
adipocyte and triglyceride accumulation, thus
attenuating adipogenesis and increased lipolysis
(44).
This study serves to investigate the action of 3’Hydoxypterostilbene on HDAC and SIRT 1 activity.
It was determined that 3’-Hydroxypterostilbene acts
as an inhibitor of HDAC. Stilbenes could be
activators or inhibitors. In this case, 3’Hydroxypterostilbene acted as both an activator and
an inhibitor of SIRT1 depending on concentration
levels. This suggests that 3’-Hydoxypterostilbene
may be further evaluated for its role in maintaining
energy for mitochondrial and/or metabolic diseases
as an activator at lower concentrations. While at
higher concentrations, 3’-Hydroxypterostilbene
may be more suitable as an inhibitor in the
prevention
and/or
treatment
of
cancers,
cardiovascular, and pulmonary diseases through
promotion of apoptosis and/or autophagy, which is
in-line with previous studies from Cheng et. al.(2);
where titrating to appropriate concentration would
be require.

was effective at inhibiting both COX-1 and -2. In
future studies it would be prudent to take a closer
look at the effects at concentrations lower than 1
µg/mL to establish a concentration-effect
relationship. It is possible that there are structural
features of 3’-Hydoxypterostilbene that competes
with cyclooxygenases to reduce inflammation.
Inhibition of PGE2 synthesis appears to be an
attractive target for management of cancer and
inflammation. Oxidative stress is of clinical
importance not only because oxidants are common
in inflammation, but also because of disruption of
mitochondrial energy metabolism. This disruption
can lead to a breach of the gastrointestinal barrier
function, which can cause mucosal barrier
permeability and lead to the initiation and/or
perturbation of mucosal inflammation. Disturbance
of colonocytes may also impair the ability to
combat free oxygen radicals responsible for cell
damage involved in colitis. Current drug therapies
including 5-aminosalicyclic acid, corticosteroids,
and immunomodulators, at times exacerbate the
patient’s disease (36-37). These therapies and
surgery can have significant side effects and
morbidity. There is a current need for new and/or
adjunctive treatments to effectively manage these
diseases without these side effects. Vitamins and
other micronutrients, including polyphenols
involved in nutrient metabolism and modulation of
oxidative stress (anti-oxidants), have demonstrated
importance because of their protective roles in the
prevention and treatment of nutrient deficiencies
and in the amelioration of disease activity in
individuals with IBD (38-39). Data from this study
suggests that it is possible that 3’Hydoxypterostilbene can aid in reducing colitis by
reducing inflammation and help maintain lowered
levels of oxidative stress.
Histone acetylases (HATs) are enzymes that
acetylate histones on lysine residues. In conjunction,
histone deacetylases (HDAC) are enzymes that can
remove excess acetyl groups primarily histone
lysine residues. If the balance of HAT and HDAC
activity is left unchecked negative long term affects
may result, affecting transcription by over
condensing chromatin and repressing the
transcription process thereby affecting normal gene
expression, thus implying roles in diseases like
cancer and inflammatory diseases (20, 40-42).
Sirtuins are protein deacetylases dependent on
nicotinamide adenine dinucleotide (NAD+) or class
III HDACs but are structurally different from class I
and II HDACs as the catalytic domain requires the

CONCLUSIONS
In
summary,
3’-Hydroxypterostilbene
was
demonstrated to have anti-adipogenic, antiinflammatory, anti-oxidant, HDAC, and SIRT1
inhibitory activity for the first time. Collectively,
the increased anti-oxidant, anti-adipogenic activity,
cell selectivity and COX-2 specificity of 3’Hydroxypterostilbene is in support of its activity in
prevention of cardiovascular and pulmonary
diseases. Coupled with HDAC and SIRT1 activity,
3’-Hydroxypterostilbene demonstrates protective
effects from neurodegenerative diseases and select
cancers. Further pharmacodynamic investigations
of 3’-Hydroxypterostilbene in inhibition of
adipogenesis, inflammation, and SIRT1 are
underway based on these preliminary investigations.
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